[Federal Register Volume 77, Number 42 (Friday, March 2, 2012)]
[Notices]
[Page 12858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-5039]



[[Page 12858]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
USC, as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    .Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel NIDA-K Special Emphasis Panel (SEP).
    Date: March 6, 2012.
    Time: 4:30 p.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Nadine Rogers, Ph.D., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-2105, <a href="/cdn-cgi/l/email-protection#04766b636176776a36446a6d60652a6a6d6c2a636b72"><span class="__cf_email__" data-cfemail="681a070f0d1a1b065a2806010c0946060100460f071e">[email protected]</span></a>
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Collaborative Clinical Trials in Drug Abuse.
    Date: March 13, 2012.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-6626, <a href="/cdn-cgi/l/email-protection#7a1d174b4e4f1b3a141312541d150c"><span class="__cf_email__" data-cfemail="d6b1bbe7e2e3b796b8bfbef8b1b9a0">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Multisite Medications Development for SUDs.
    Date: March 15, 2012.
    Time: 11 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-6626, <a href="/cdn-cgi/l/email-protection#05626834313064456b6c6d2b626a73"><span class="__cf_email__" data-cfemail="c9aea4f8fdfca889a7a0a1e7aea6bf">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, 2012 Translational Avant Garde Review (DP1).
    Date: March 27, 2012.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn, 7301 Waverly Street, Bethesda, MD 
20814.
    Contact Person: Scott A. Chen, Ph.D., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 4234, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-443-9511, <a href="/cdn-cgi/l/email-protection#87e4efe2e9f4e4c7eae6eeeba9e9eeefa9e0e8f1"><span class="__cf_email__" data-cfemail="c7a4afa2a9b4a487aaa6aeabe9a9aeafe9a0a8b1">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, DIDARP Review.
    Date: March 30, 2012.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Nadine Rogers, Ph.D., Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, 
Bethesda, MD 20892-9550, 301-402-2105, <a href="/cdn-cgi/l/email-protection#2f5d40484a5d5c411d6f41464b4e0141464701484059"><span class="__cf_email__" data-cfemail="10627f777562637e22507e7974713e7e79783e777f66">[email protected]</span></a>.

 (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, 
Drug Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-5039 Filed 3-1-12; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>